Dermazin Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

The following frequencies are used for the description of side effects: Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥ 1/10,000 to < 1/1,000); Very rare (< 1/10,000); Not known (cannot be estimated from the available data).
The following adverse reactions have been reported during post-marketing use, and in the scientific literature.
Blood and lymphatic system disorders: Uncommon: Leukopenia.
Not known: Increased serum osmolality.
Immune system disorders: Not known: Hypersensitivity.
Skin and subcutaneous tissue disorders: Very rare: Severe cutaneous adverse reactions (SCARs): Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported (see Precautions).
Not known: Allergic skin reactions such as rash, pruritus, contact dermatitis. Gray discoloration of the skin under the influence of sunlight.
General disorders and administration site conditions: Unknown: Burning sensation or pain.
Systemic absorption of silver sulfadiazine can very rarely cause side effects associated with systemic sulfonamide therapy.

View ADR Reporting Link

Dermazin Adverse Reactions

silver sulfadiazine

Manufacturer:

Sandoz

Distributor:

Zuellig Pharma